ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,308, issued on Dec. 2, was assigned to LGV1 S.R.L. (Naples, Italy).
"Variant of a BPIFB4 protein" was invented by Annibale Alessandro Puca (Naples, Italy) and Carmine Vecchione (Villapiana Scalo, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a variant of BPIFB4 protein (Bactericidal/Permeability Increasing protein family B, member 4) and to a polynucleotide or a vector encoding said variant of BPIFB4 protein and to their use for the treatment of pathologies involving impairment of nitric oxide signalling."
The patent was filed on Dec. 19, 2023, under Application No. 18/545,302.
*For further information, inclu...